
Breast Cancer Core Needle Biopsy Market Growth, Size, Trends Analysis - By Technology, By End-use- Regional Outlook, Competitive Strategies and Segment Forecast to 2034
Description
Breast Cancer Core Needle Biopsy Market Introduction and Overview
According to SPER market research, ‘Global Breast Cancer Core Needle Biopsy Market Size- By Technology, By End-use – Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ state that the Global Breast Cancer Core Needle Biopsy Market is predicted to reach 1398.03 million by 2034 with a CAGR of 4.86%.
Breast cancer core needle biopsy is a minimally invasive diagnostic method that takes small samples of breast tissue for examination. To recover tissue cores, a hollow needle is placed into the suspicious area, guided by imaging modalities such as ultrasonography, mammography, or MRI. This approach accurately detects malignant cells while providing minimal discomfort and avoiding the need for surgical biopsy.
Restraints: The breast cancer core needle biopsy market faces various challenges that could hamper its growth. One key impediment is the growing demand for less invasive diagnostic methods like as liquid biopsies and micro needle aspiration, which can be more cost-effective. Furthermore, stringent regulatory requirements for product licensing and clinical validation can cause delays in the introduction of new technologies, increasing development costs and limiting market entry for smaller businesses.
Scope of the report:
Report Metric Details
Market size available for years 2021-2034
Base year considered 2024
Forecast period 2025-2034
Segments covered
By Technology, By End-use
Regions covered
North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa
Companies Covered
Argon Medical Devices, Becton - Dickinson and Company, C.R. Bard, Inc., Cook Medical Incorporated, Encapsule Medical Devices LLC, Ethicon Surgical Technologies, Gallini SRL, Hologic, Inc., Intact Medical Corporation, Leica Biosystems Nussloch GmbH.
By Technology:
Based on the Technology, Global Breast Cancer Core Needle Biopsy Market is segmented as; MRI-based Breast Biopsy, Ultrasound-based Breast Biopsy, Mammography-based Breast Biopsy, CT-based Breast Biopsy, Other Image Based Breast Biopsy.
By End-use:
Based on the End-use: Global Breast Cancer Core Needle Biopsy Market is segmented as; Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes.
By Region:
This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.
According to SPER market research, ‘Global Breast Cancer Core Needle Biopsy Market Size- By Technology, By End-use – Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ state that the Global Breast Cancer Core Needle Biopsy Market is predicted to reach 1398.03 million by 2034 with a CAGR of 4.86%.
Breast cancer core needle biopsy is a minimally invasive diagnostic method that takes small samples of breast tissue for examination. To recover tissue cores, a hollow needle is placed into the suspicious area, guided by imaging modalities such as ultrasonography, mammography, or MRI. This approach accurately detects malignant cells while providing minimal discomfort and avoiding the need for surgical biopsy.
Restraints: The breast cancer core needle biopsy market faces various challenges that could hamper its growth. One key impediment is the growing demand for less invasive diagnostic methods like as liquid biopsies and micro needle aspiration, which can be more cost-effective. Furthermore, stringent regulatory requirements for product licensing and clinical validation can cause delays in the introduction of new technologies, increasing development costs and limiting market entry for smaller businesses.
Scope of the report:
Report Metric Details
Market size available for years 2021-2034
Base year considered 2024
Forecast period 2025-2034
Segments covered
By Technology, By End-use
Regions covered
North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa
Companies Covered
Argon Medical Devices, Becton - Dickinson and Company, C.R. Bard, Inc., Cook Medical Incorporated, Encapsule Medical Devices LLC, Ethicon Surgical Technologies, Gallini SRL, Hologic, Inc., Intact Medical Corporation, Leica Biosystems Nussloch GmbH.
By Technology:
Based on the Technology, Global Breast Cancer Core Needle Biopsy Market is segmented as; MRI-based Breast Biopsy, Ultrasound-based Breast Biopsy, Mammography-based Breast Biopsy, CT-based Breast Biopsy, Other Image Based Breast Biopsy.
By End-use:
Based on the End-use: Global Breast Cancer Core Needle Biopsy Market is segmented as; Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes.
By Region:
This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.
Table of Contents
248 Pages
- 1. Introduction
- 1.1. Scope of the report
- 1.2. Market segment analysis
- 2. Research Methodology
- 2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPERs internal database
- 2.1.4. Premium insight from KOLs
- 2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
- 2.3. Data triangulation
- 3. Executive Summary
- 4. Market Dynamics
- 4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges
- 5. Market variable and outlook
- 5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
- 5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
- 5.3. PORTERs Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
- 5.4. Heat Map Analysis
- 6. Competitive Landscape
- 6.1. Global Breast Cancer Core Needle Biopsy Market Manufacturing Base Distribution, Sales Area, Product Type
- 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Breast Cancer Core Needle Biopsy Market
- 7. Global Breast Cancer Core Needle Biopsy Market, By Technology (USD Million) 2021-2034
- 7.1. MRI-based Breast Biopsy
- 7.2. Ultrasound-based Breast Biopsy
- 7.3. Mammography-based (Stereotactic) Breast Biopsy
- 7.4. CT-based Breast Biopsy
- 7.5. Other Image Based Breast Biopsy
- 8. Global Breast Cancer Core Needle Biopsy Market, By End-Use (USD Million) 2021-2034
- 8.1. Hospitals & Diagnostic Laboratories
- 8.2. Pharmaceutical & Biotechnology Companies
- 8.3. Academic & Research Institutes
- 9. Global Breast Cancer Core Needle Biopsy Market, (USD Million) 2021-2034
- 9.1. Global Breast Cancer Core Needle Biopsy Market Size and Market Share
- 10. Global Breast Cancer Core Needle Biopsy Market, By Region, (USD Million) 2021-2034
- 10.1. Asia-Pacific
- 10.1.1. Australia
- 10.1.2. China
- 10.1.3. India
- 10.1.4. Japan
- 10.1.5. South Korea
- 10.1.6. Rest of Asia-Pacific
- 10.2. Europe
- 10.2.1. France
- 10.2.2. Germany
- 10.2.3. Italy
- 10.2.4. Spain
- 10.2.5. United Kingdom
- 10.2.6. Rest of Europe
- 10.3. Middle East and Africa
- 10.3.1. Kingdom of Saudi Arabia
- 10.3.2. United Arab Emirates
- 10.3.3. Qatar
- 10.3.4. South Africa
- 10.3.5. Egypt
- 10.3.6. Morocco
- 10.3.7. Nigeria
- 10.3.8. Rest of Middle-East and Africa
- 10.4. North America
- 10.4.1. Canada
- 10.4.2. Mexico
- 10.4.3. United States
- 10.5. Latin America
- 10.5.1. Argentina
- 10.5.2. Brazil
- 10.5.3. Rest of Latin America
- 11. Company Profile
- 11.1. Argon Medical Devices
- 11.1.1. Company details
- 11.1.2. Financial outlook
- 11.1.3. Product summary
- 11.1.4. Recent developments
- 11.2. Becton- Dickinson and Company
- 11.2.1. Company details
- 11.2.2. Financial outlook
- 11.2.3. Product summary
- 11.2.4. Recent developments
- 11.3. C. R. Bard, Inc.
- 11.3.1. Company details
- 11.3.2. Financial outlook
- 11.3.3. Product summary
- 11.3.4. Recent developments
- 11.4. Cook Medical Incorporated
- 11.4.1. Company details
- 11.4.2. Financial outlook
- 11.4.3. Product summary
- 11.4.4. Recent developments
- 11.5. Encapsule Medical Devices LLC
- 11.5.1. Company details
- 11.5.2. Financial outlook
- 11.5.3. Product summary
- 11.5.4. Recent developments
- 11.6. Ethicon Surgical Technologies
- 11.6.1. Company details
- 11.6.2. Financial outlook
- 11.6.3. Product summary
- 11.6.4. Recent developments
- 11.7. Gallini SRL
- 11.7.1. Company details
- 11.7.2. Financial outlook
- 11.7.3. Product summary
- 11.7.4. Recent developments
- 11.8. Hologic, Inc.
- 11.8.1. Company details
- 11.8.2. Financial outlook
- 11.8.3. Product summary
- 11.8.4. Recent developments
- 11.9. Intact Medical Corporation
- 11.9.1. Company details
- 11.9.2. Financial outlook
- 11.9.3. Product summary
- 11.9.4. Recent developments
- 11.10. Leica Biosystems Nuss Loch GmbH
- 11.10.1. Company details
- 11.10.2. Financial outlook
- 11.10.3. Product summary
- 11.10.4. Recent developments
- 11.11. Others
- 12. Conclusion
- 13. List of Abbreviations
- 14. Reference Links
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.